BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 25519926)

  • 1. The Ability to Diagnose Intrahepatic Cholangiocarcinoma Definitively Using Novel Branched DNA-Enhanced Albumin RNA In Situ Hybridization Technology.
    Ferrone CR; Ting DT; Shahid M; Konstantinidis IT; Sabbatino F; Goyal L; Rice-Stitt T; Mubeen A; Arora K; Bardeesey N; Miura J; Gamblin TC; Zhu AX; Borger D; Lillemoe KD; Rivera MN; Deshpande V
    Ann Surg Oncol; 2016 Jan; 23(1):290-6. PubMed ID: 25519926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Subset of Intrahepatic Cholangiocarcinomas Express Albumin RNA as Detected by In Situ Hybridization.
    Avadhani V; Cohen C; Siddiqui MT; Krasinskas A
    Appl Immunohistochem Mol Morphol; 2021 Mar; 29(3):175-179. PubMed ID: 33181516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility and Limitations of Albumin mRNA In Situ Hybridization Detection in the Diagnosis of Hepatobiliary Lesions and Metastatic Carcinoma to the Liver.
    Collins K; Newcomb PH; Cartun RW; Ligato S
    Appl Immunohistochem Mol Morphol; 2021 Mar; 29(3):180-187. PubMed ID: 33208670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholangiolar pattern and albumin in situ hybridisation enable a diagnosis of intrahepatic cholangiocarcinoma.
    Brackett DG; Neyaz A; Arora K; Masia R; Mattia A; Zukerberg L; Misdraji J; Goyal L; Zhu AX; Ferrone CR; Yilmaz OH; Deshpande V
    J Clin Pathol; 2020 Jan; 73(1):23-29. PubMed ID: 31422372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Albumin In Situ Hybridization Can Be Positive in Adenocarcinomas and Other Tumors From Diverse Sites.
    Nasir A; Lehrke HD; Mounajjed T; Said S; Zhang L; Yasir S; Shah SS; Chandan VS; Smyrk TC; Moreira RK; Boland Froemming JM; Herrera Hernandez LP; Wu TT; Graham RP
    Am J Clin Pathol; 2019 Jul; 152(2):190-199. PubMed ID: 31107526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of Albumin Expression by RNA In Situ Hybridization Is a Sensitive and Specific Method for Identification of Hepatocellular Carcinomas and Intrahepatic Cholangiocarcinomas.
    Lin F; Shi J; Wang HL; Ma XJ; Monroe R; Luo Y; Chen Z; Liu H
    Am J Clin Pathol; 2018 May; 150(1):58-64. PubMed ID: 29746696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on Ancillary Testing in the Evaluation of High-Grade Liver Tumors.
    Koehne de Gonzalez A; Lagana SM
    Surg Pathol Clin; 2018 Jun; 11(2):367-375. PubMed ID: 29751880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Branched chain in situ hybridization for albumin as a marker of hepatocellular differentiation: evaluation of manual and automated in situ hybridization platforms.
    Shahid M; Mubeen A; Tse J; Kakar S; Bateman AC; Borger D; Rivera MN; Ting DT; Deshpande V
    Am J Surg Pathol; 2015 Jan; 39(1):25-34. PubMed ID: 25353287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Albumin expression distinguishes bile duct adenomas from metastatic adenocarcinoma.
    Moy AP; Arora K; Deshpande V
    Histopathology; 2016 Sep; 69(3):423-30. PubMed ID: 26841202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The utility of villin and mammaglobin in the differential diagnosis between intrahepatic cholangiocarcinoma and breast cancer.
    Yang Z
    Appl Immunohistochem Mol Morphol; 2015 Jan; 23(1):19-25. PubMed ID: 25153498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of anterior gradient protein 3 in intrahepatic cholangiocarcinoma and hepatocellular carcinoma.
    Brychtova V; Zampachova V; Hrstka R; Fabian P; Novak J; Hermanova M; Vojtesek B
    Exp Mol Pathol; 2014 Jun; 96(3):375-81. PubMed ID: 24747240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Albumin, filamin-A and cytokeratin 19 help distinguish intrahepatic cholangiocarcinoma from extrahepatic adenocarcinoma.
    Chung YS; Jeon Y; Yoo JE; Chung T; Ryu HJ; Kim H; Rhee H; Park YN
    Hepatol Int; 2023 Feb; 17(1):77-85. PubMed ID: 36253584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of primary and metastatic clear cell tumors in the liver by in situ hybridization for albumin messenger RNA.
    Oliveira AM; Erickson LA; Burgart LJ; Lloyd RV
    Am J Surg Pathol; 2000 Feb; 24(2):177-82. PubMed ID: 10680884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoreactivity of Hep Par 1 in hepatic and extrahepatic tumors and its correlation with albumin in situ hybridization in hepatocellular carcinoma.
    Kakar S; Muir T; Murphy LM; Lloyd RV; Burgart LJ
    Am J Clin Pathol; 2003 Mar; 119(3):361-6. PubMed ID: 12645337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined hepatocellular-cholangiocarcinoma: a histopathologic, immunohistochemical, and in situ hybridization study.
    Tickoo SK; Zee SY; Obiekwe S; Xiao H; Koea J; Robiou C; Blumgart LH; Jarnagin W; Ladanyi M; Klimstra DS
    Am J Surg Pathol; 2002 Aug; 26(8):989-97. PubMed ID: 12170085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Das-1 immunostain is useful for discriminating metastatic colon adenocarcinoma from cholangiocarcinoma and hepatocellular carcinoma.
    Zimmerman RL; Das KM; Fogt F; Burke M; Murakata LA
    Oncol Rep; 2002; 9(6):1369-72. PubMed ID: 12375050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of albumin RNAscope in situ hybridization in diagnosis and differential diagnosis of hepatocellular carcinoma].
    Chen XY; Dong L; Wang CF
    Zhonghua Bing Li Xue Za Zhi; 2022 May; 51(5):400-406. PubMed ID: 35511634
    [No Abstract]   [Full Text] [Related]  

  • 18. Small intrahepatic mass-forming cholangiocarcinoma: target sign on diffusion-weighted imaging for differentiation from hepatocellular carcinoma.
    Park HJ; Kim YK; Park MJ; Lee WJ
    Abdom Imaging; 2013 Aug; 38(4):793-801. PubMed ID: 22829097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S100P immunostaining identifies a subset of peripheral-type intrahepatic cholangiocarcinomas with morphological and molecular features similar to those of perihilar and extrahepatic cholangiocarcinomas.
    Tsai JH; Huang WC; Kuo KT; Yuan RH; Chen YL; Jeng YM
    Histopathology; 2012 Dec; 61(6):1106-16. PubMed ID: 22882148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methylation biomarkers for diagnosis of primary liver cancer and distinguishing hepatocellular carcinoma from intrahepatic cholangiocarcinoma.
    Bai Y; Tong W; Xie F; Zhu L; Wu H; Shi R; Wang L; Yang L; Liu Z; Miao F; Zhao Q; Zhang Y
    Aging (Albany NY); 2021 Jul; 13(13):17592-17606. PubMed ID: 34237708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.